close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Novo Nordisk A/S Investment Strategy Stock Picks
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Eisai Co Ltd Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Companies Business Clinical trials
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Pharmaceuticals Eli Lilly and Co Health care industry
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Health care industry Science Health & Science
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Markets Mad Money Investing
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Pfizer Inc Health care industry Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investing Markets 5 Things to Know
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Novo Nordisk A/S Health & Science Pharmaceuticals
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Target Corp Investment strategy Monday/Com Ltd
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags Dream Finders Homes Inc Market Outlook Gogo Inc
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Eli Lilly and Co Pharmaceuticals Breaking News: Business
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Business News Social issues Business
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Pfizer Inc Health care industry Eli Lilly and Co
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Business News US: News US Top News and Analysis
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Health care industry Health & Science Biotechnology
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Health & Science Seagen Inc Biotechnology
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Mobile Alphabet Inc Apple Inc
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Chevron Corp Alphabet Inc Markets
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Exxon Mobil Corp World Markets Intel Corp
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Investment strategy Eli Lilly and Co Health care industry
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags Sanofi SA Health care industry CVS Health Corp
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Health care industry Biotechnology Wall Street
From CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
Tags Business Companies US: News
From CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Tickers BIRK EVS MSFT NVO
Tags electric vehicles Novo Nordisk Tesla
From Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
Tags Business News Abbott Laboratories stocks
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
Tags Exxon Mobil Corp Plug Power Inc Breaking News: Markets
From CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
Tags Finance Pioneer Natural Resources Co Economy
From CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
Tags Novo Nordisk A/S Europe Markets Earnings
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Diabetes US: News Consumer Finance
From CNBC.com News
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today